| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2014-08-20 | Covidien (Ireland) | Covidien Center of Innovation Brazil (CCI Brazil) | Establishment of a new subsidiary in the EU | |||
| 2014-08-19 | Baxter (USA - IL) | Renal diseases - Kidney diseases | Construction of a production plant | |||
| 2014-08-19 | Roche (Switzerland) the Garvan Institute of Medical Research (USA - CA) | new technologies for targeted epigenomic analysis | R&D agreement | |||
| 2014-08-19 | Evotec (Germany) Medicines For Malaria Venture | Malaria Box, Pathogen Box | malaria, neglected diseases | Infectious diseases - Parasitic diseases | Collaboration agreement | |
| 2014-08-18 | Eisai (Japan) Zeria Pharmaceutical (Japan) | E3710 | gastric acid secretion, gastritis, gastric ulcer | Gastrointestinal diseases - Digestive diseases | Licensing agreement | |
| 2014-08-14 | MDxHealth (Belgium) Ancillary Care Services (USA - TX) | ConfirmMDx® for Prostate Cancer | prostate cancer | collaboration agreement |
Cancer - Oncology | Collaboration agreement |
| 2014-08-14 | MDxHealth (Belgium) Consilium (USA - FL) | ConfirmMDx® for Prostate Cancer | prostate cancer | collaboration agreement |
Cancer - Oncology | Collaboration agreement |
| 2014-08-14 | Melinta Therapeutics (USA - CT) | member of the board of directors | nomination | Infectious diseases | Nomination | |
| 2014-08-13 | RedHill Biopharma (Israel) RESprotect (Germany) | RP101 and next generation compounds | licensing |
Cancer - Oncology | Licensing agreement | |
| 2014-08-12 | Pfizer (USA - NY) 23andMe (USA - CA) | inflammatory bowel disease (IBD), Crohn’s disease, ulcerative colitis | Autoimmune diseases - Inflammatory diseases - Digestive diseases | R&D agreement | ||
| 2014-08-11 | Human Longevity (USA - CA) Celgene Cellular Therapeutics (USA - CA) | placental cell population PSC-100 | sarcopenia | Development agreement | ||
| 2014-08-11 | Prosensa (The Netherlands) CureDuchenne (USA - CA) | PRO044, PRO045, PRO053, drisapersen | Duchenne Muscular Dystrophy | collaboration agreement |
Genetic diseases - Neuromuscular diseases - Rare diseases | Collaboration agreement |
| 2014-08-08 | Nicox (France) Bausch + Lomb (USA - NJ) | latanoprostene bunod | glaucoma, ocular hypertension | Ophtalmological diseases | Exercise of an option agreement | |
| 2014-08-07 | Access Pharmaceuticals (USA - TX) Norgine (The Netherlands) | MuGard™ | oral mucositis | licensing agreement |
Cancer - Oncology - Inflammatory diseases | Licensing agreement |
| 2014-08-07 | Immune Design (USA - MA) Sanofi (France) | GLAAS™ discovery platform | undisclosed food allergy | Allergic diseases - Immunological diseases | Licensing agreement | |
| 2014-08-07 | Baxter (USA - IL) | Advate®, Rixubis®, BAX 855 | hemophilia A, hemophilia B | Hematological diseases - Genetic diseases - Rare diseases | Validation of a production plant | |
| 2014-08-07 | Cancer Research UK (UK) Cancer Research Technology (UK) Astellas (Japan) | new drug targets for pancreatic cancer | pancreatic cancer. | R&D agreement |
Cancer - Oncology | R&D agreement |
| 2014-08-07 | BMS (USA - NY) Leica Biosystems (Germany) | tissue-based companion diagnostic tests | undisclosed | development agreement |
undisclosed | Development agreement |
| 2014-08-06 | Valneva (France - Austria) Geovax (USA) | MVA-based vaccines in Valneva’s EB66® vaccine production cell line | HIV/AIDS | development manufacturing |
Infectious diseases | Licensing agreement |
| 2014-08-06 | Mesoblast (Australia) National Heart, Lung and Blood Institute, NIH (USA) | Mesenchymal Precursor Cells (MPCs) | congestive heart failure, advanced heart failure | collaboration |
Cardiovascular diseases - Regenerative medicine | Collaboration agreement |
